Useful links
Unit of study_
PHAR7826: Advanced Therapies: Development and Regulation
2024 unit information
This unit will give students the skills to understand how advanced therapy products, such as cell and gene therapies, are researched, developed and regulated. The regulatory requirements for chemistry, manufacturing and controls, pre-clinical testing including toxicity studies, and clinical testing will be discussed. Finally, the unit will examine the regulatory requirements for registration of these types of products in Australia and globally.
Unit details and rules
Managing faculty or University school:
Pharmacy
| Code | PHAR7826 |
|---|---|
| Academic unit | Pharmacy |
| Credit points | 6 |
|
Prerequisites:
?
|
None |
|---|---|
|
Corequisites:
?
|
None |
| Prohibitions:
?
|
PCOL5102 |
| Assumed knowledge:
?
|
None |
The learning outcomes for this unit will be available two weeks before the first day of teaching.
Unit availability
This section lists the session, attendance modes and locations the unit is available in. There is a unit outline for each of the unit availabilities, which gives you information about the unit including assessment details and a schedule of weekly activities.
The outline is published 2 weeks before the first day of teaching. You can look at previous outlines for a guide to the details of a unit.
| Session | MoA ? | Location | Outline ? |
|---|---|---|---|
|
Semester 2 2024
|
Online | Camperdown/Darlington, Sydney |
Outline unavailable
|
There are no availabilities for previous years.
Modes of attendance (MoA)
This refers to the Mode of attendance (MoA) for the unit as it appears when you’re selecting your units in Sydney Student. Find more information about modes of attendance on our website.
